Slide background
Slide background




EudraBook Compendium of EU pharmaceutical law

ID 6831 | | Visite: 13373 | MedicinalPermalink: https://www.certifico.com/id/6831

EudraBook

EudraBook Compendium of EU pharmaceutical law

2015 marks the 50th anniversary of pharmaceutical legislation in the EU, which began with Directive 65/65 in 1965 in the wake of the Thalidomide disaster.

The EU legal framework for medicinal products for human use guarantees high standards of quality and safety of medicinal products and intends to promote the functioning of the internal market, with measures which encourage innovation and competiveness in Europe. It is based on the principle that medicinal products may be placed on the market only following a marketing authorisation granted by the competent authorities.

A large body of legislation has developed around this principle, with the progressive harmonisation of requirements for the granting of marketing authorisations since the 1960s, implemented across the whole European Economic Area.

Nowadays, medicinal products may be either authorised centrally by the European Commission or nationally by Member States’ competent authorities. The European Medicines Agency, established in 1995, underpins the centralised authorisation procedure and supports coordination between national competent authorities. The Agency is the hub of a European medicines network comprising over 40 national regulatory authorities guaranteeing a constant exchange and flow of information regarding the scientific assessment of medicinal products in the EU.

The EU legal framework is definitely not an area in which the law stands still. Quite the contrary, its history is marked by a constant ambition to improve its functioning or tackling shortcomings in order to guarantee the right balance between early access of patients to new medicines and high standards of quality and safety. Moreover, over the past 50 years science has developed. New technologies and further knowledge about diseases led to the introduction of new concepts or re-shaping of existing medical therapies that were subsequently mirrored in legislation.

The pharmaceutical sector is characterised by an abundance of guidelines intended to help and support the key players in the application of the EU legal framework. Still, the guidance documents would be nothing without the basic legislation on which they build.

To understand the EU legal framework for medicinal products it is important to know the applicable provisions of the legislation itself. This E-Book is intended to support readers in this regard by putting together the most recent versions of the key legal instruments on medicinal products for human use. It provides a useful overview for stakeholders, especially the pharmaceutical industry, regulatory authorities, legal practitioners, but also interested citizens, patients and healthcare professionals.

This E-Book reflects the law as it stands on 1 January 2015

Eudralex Ebook Version 1.3 06/05/2015

DescrizioneLinguaDimensioneDownloads
Scarica questo file (EudraBook Compendium of EU pharmaceutical law 2015.pdf)EudraBook Compendium of EU pharmaceutical law 2015
 
EN1558 kB1178

Tags: Medicinal

Ultimi archiviati Chemicals

ECHA Annual report 2024
Apr 19, 2025 522

ECHA Annual report 2024

ECHA Annual report 2024 ID 23848 | 19.04.2025 / Attached ECHA’s achievements in 2024 reflect a strong commitment to our strategic goals and priorities, as well as our vision of chemical safety through science, collaboration and knowledge. We continued to progress and implement our existing legal… Leggi tutto
Piano nazionale di controllo ufficiale degli additivi e aromi alimentari 2025 2027
Apr 17, 2025 615

Piano nazionale di controllo ufficiale degli additivi e aromi alimentari 2025-2027

Piano nazionale di controllo ufficiale degli additivi e aromi alimentari 2025-2027 ID 23839 | 17.04.2025 / In allegato Piano nazionale di controllo ufficiale degli additivi e aromi alimentari come materia prima e negli alimenti comprese le sostanze aromatizzanti di affumicatura anni 2025-2027 Il… Leggi tutto
Apr 08, 2025 756

Decreto 27 marzo 2025 | Suppl. 11.7 Farmacopea europea 11ª ed.

Decreto 27 marzo 2025 | Suppl. 11.7 Farmacopea europea 11ª ed. ID 23772 | 08.04.2025 Decreto 27 marzo 2025 Entrata in vigore dei testi, nelle lingue inglese e francese, pubblicati nel supplemento 11.7 della 11ª edizione della Farmacopea europea. (GU n.82 del 08.04.2025) _________ Art. 1. 1. I testi… Leggi tutto
Apr 07, 2025 751

Regolamento delegato (UE) 2025/687

Regolamento delegato (UE) 2025/687 ID 23761 | 07.04.2025 Regolamento delegato (UE) 2025/687 della Commissione, del 30 gennaio 2025, che modifica il regolamento delegato (UE) 2019/624 per quanto riguarda le ispezioni ante mortem presso i macelli, le ispezioni ante mortem presso l’azienda di… Leggi tutto
Mar 20, 2025 847

Regolamento delegato (UE) 2020/1413

Regolamento delegato (UE) 2020/1413 ID 23662 | 20.03.2025 Regolamento delegato (UE) 2020/1413 della Commissione del 29 giugno 2020 che rettifica la versione in lingua svedese dell’allegato I del regolamento (CE) n. 1272/2008 del Parlamento europeo e del Consiglio relativo alla classificazione,… Leggi tutto
IARC Monograph Volume 58
Mar 17, 2025 853

IARC Monographs Volume 58 / 1993

IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 58 / IARC 1993 ID 23643 | 17.03.2025 / Attached Beryllium, Cadmium, Mercury, and Exposures in the Glass Manufacturing Industry Evaluates the carcinogenic risk to humans posed by exposure to selected metals and their compounds.… Leggi tutto

Più letti Chemicals

Notifica HACCP
Apr 05, 2022 98834

Notifica ai fini registrazione Regolamento CE n. 852/2004

Notifica ai fini della registrazione (Reg. CE n. 852/2004) - Ex notifica sanitaria alimentare ID 7901 | 06.03.2019 / Modello notifica allegato [panel]Regolamento (CE) 852/2004...Articolo 6 Controlli ufficiali, registrazione e riconoscimento 1. Gli operatori del settore alimentare collaborano con le… Leggi tutto